Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

24.37

+1.70 (7.50%)

At close: Nov 11, 2025, 4:00 PM EST

24.60

+0.23 (0.94%)

Pre-market: Nov 12, 2025, 8:00 AM EST

Celldex Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Nov '25 Nov 11, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	1,619	1,677	2,169	2,099	1,803	693	Upgrade
Market Cap Growth	-13.16%	-22.71%	3.32%	16.42%	160.10%	1759.97%	Upgrade
Enterprise Value	1,039	924	1,936	1,779	1,383	497	Upgrade
Last Close Price	24.37	25.27	39.66	44.57	38.64	17.52	Upgrade
PS Ratio	623.08	238.82	315.12	890.64	387.68	93.45	Upgrade
PB Ratio	2.71	2.24	5.05	6.44	4.30	3.31	Upgrade
P/TBV Ratio	2.84	2.33	5.40	7.02	4.60	3.88	Upgrade
EV/Sales Ratio	399.68	131.57	281.34	754.94	297.37	67.06	Upgrade
Debt / Equity Ratio	0.00	0.01	0.01	0.01	0.01	0.02	Upgrade
Asset Turnover	0.00	0.01	0.02	0.01	0.01	0.04	Upgrade
Quick Ratio	12.55	18.38	13.69	16.41	24.71	13.81	Upgrade
Current Ratio	13.01	18.92	13.87	17.07	24.86	13.93	Upgrade
Return on Equity (ROE)	-32.44%	-26.84%	-37.45%	-30.13%	-22.43%	-39.41%	Upgrade
Return on Assets (ROA)	-21.77%	-19.38%	-21.70%	-16.79%	-12.70%	-17.27%	Upgrade
Return on Capital (ROIC)	-23.04%	-20.62%	-23.30%	-17.78%	-13.60%	-19.96%	Upgrade
Earnings Yield	-13.87%	-9.42%	-6.52%	-5.35%	-3.91%	-8.62%	Upgrade
FCF Yield	-11.22%	-9.53%	-5.03%	-5.03%	-3.45%	-6.05%	Upgrade
Buyback Yield / Dilution	-9.16%	-32.91%	-3.33%	-9.37%	-44.64%	-104.31%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q